# Ken Prima Cosmeceuticals, Sdn. Bhd., Perai, Malaysia – FDA Inspections

Source: https://www.keypedia.com/companies/ken-prima-cosmeceuticals-sdn-bhd/db059ae4-0c79-487b-970f-e14bb6bee314

> Inspection records and compliance data for Ken Prima Cosmeceuticals, Sdn. Bhd. in Perai. 3 FDA inspections on record (1 OAI), 2 Form 483s, last inspected November 17, 2023.

---

## Details

- Name: Ken Prima Cosmeceuticals, Sdn. Bhd.
- FEI Number: 3010026101
- Address Line 1: Plot 22, Lorong Perusahaan Maju 2, Prai Industrial Estate Phase 4
- City: Perai
- Country Name: Malaysia
- Address: Plot 22, Lorong Perusahaan Maju 2, Prai Industrial Estate Phase 4, Perai, Malaysia
- Country: Malaysia

## Related Documents

- [483 - Ken Prima Cosmeceuticals, Sdn. Bhd. - 2023-11-17](https://www.keypedia.com/records/483/ken-prima-cosmeceuticals-sdn-bhd/91492896-73ac-4595-a211-94cdd16f2d1b) — source: FDA, date: November 17, 2023
- [FDA Inspection 1223306 - Ken Prima Cosmeceuticals, Sdn. Bhd. - 2023-11-17](https://www.keypedia.com/records/fda_inspections/ken-prima-cosmeceuticals-sdn-bhd/54f11c3b-d308-417f-855a-83b004e53ae7) — classification: Official Action Indicated (OAI), source: FDA, date: November 17, 2023
- [FDA Inspection 1025931 - Ken Prima Cosmeceuticals, Sdn. Bhd. - 2017-09-21](https://www.keypedia.com/records/fda_inspections/ken-prima-cosmeceuticals-sdn-bhd/52ca1ccf-4aaa-411c-bbdc-3eaaa93359cd) — classification: Voluntary Action Indicated (VAI), source: FDA, date: September 21, 2017
- [FDA Inspection 889623 - Ken Prima Cosmeceuticals, Sdn. Bhd. - 2014-07-16](https://www.keypedia.com/records/fda_inspections/ken-prima-cosmeceuticals-sdn-bhd/b38317e4-68fe-4d5d-860d-1eb9bd3ee027) — classification: Voluntary Action Indicated (VAI), source: FDA, date: July 16, 2014

## Related Companies

- [Kwabena (NMI) Ayesu, M.D.](https://www.keypedia.com/companies/kwabena-nmi-ayesu-md/9e5eea3e-0997-4f23-a9f3-935bec5b4c97)
- [Johnnie M. Woodson, MD](https://www.keypedia.com/companies/johnnie-m-woodson-md/74dec455-8530-4460-8021-f1e191a8f29a)
- [Robert Hayashi M.D](https://www.keypedia.com/companies/robert-hayashi-md/d086cfb8-b6fd-4ae5-be14-e381f7f84a4b)
- [Long Grove Pharmaceuticals LLC](https://www.keypedia.com/companies/long-grove-pharmaceuticals-llc/efe5576b-de03-4c98-ad6c-6cda45364d63)
- [Peter Karachunski, M.D.](https://www.keypedia.com/companies/peter-karachunski-md/1a8973f9-8fd0-44da-b9b5-6c3c9d9292ad)
- [Lily C. Chao, M.D.](https://www.keypedia.com/companies/lily-c-chao-md/ce04559f-4b2d-424d-92c2-20690a452401)
- [University of Texas Health Science Center At San Antonio, The](https://www.keypedia.com/companies/university-of-texas-health-science-center-at-san-antonio-the/00452750-2d02-469c-a22b-d8346ec85814)
- [Celgene Corp., d.b.a. Abraxis BioScience LLC](https://www.keypedia.com/companies/celgene-corp-dba-abraxis-bioscience-llc/adaf2a93-2132-4073-a969-3ca7da90dff8)
- [Shirish M. Gadgeel, MD](https://www.keypedia.com/companies/shirish-m-gadgeel-md/5361a7ef-30af-4112-b608-a324baad6f3d)
- [Partner Therapeutics, Inc.](https://www.keypedia.com/companies/partner-therapeutics-inc/02b6f3e3-ef3e-4352-9f94-1e462de5f2b4)

## Related Officers

- [Research Specialist II](https://www.keypedia.com/people/justin-a-boyd/796c9c9d-02db-486c-bdca-cc259066a0e2)